# Peregrine Ventures

> Peregrine Ventures is a VC fund backing Health Care and Medical Device. See 180 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Or Yehuda, Israel
- Total investments: 180
- Last investment: Feb 2026
- Lead investor: 5%
- Fund size: $30M
- Last fund: Apr 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/peregrinevc/about/
- Website: http://www.peregrinevc.com

Peregrine Ventures is a VC fund in Or Yehuda focused on Health Care and Medical Device. Peregrine Ventures, a leading healthcare fund based in Israel, is committed to improving patients' quality of life by investing in and supporting game-changing healthcare opportunities. As a global life science venture capital fund, Peregrine invests throughout a company’s life cycle to help facilitate growth and success and offers creativebusiness solutions to suit the needs of its portfolio companies. From seed-stage opportunities to more mature companies, Peregrine’s specifically defined funds offer portfolio companies complete, end-to-end investment solutions that have helped bring healthcare innovations to fruition for over 20 years. Peregrine’s robust portfolio includes first and best-in-class global companies, in the fields of biotech, medical devices, and digital health. Peregrine’s mature funds maintain their strong position in the upper quartile of the industry’s leading benchmarks .

## Contacts

5 contacts available for Peregrine Ventures. Shizune tracks 10 team members at Peregrine Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/peregrine-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 42 | 23% |
| Medical Device | 29 | 16% |
| Biotechnology | 23 | 13% |
| Medical | 22 | 12% |
| Software | 13 | 7% |

91 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 51 | 28% |
| Venture - Series Unknown | 26 | 14% |
| Series A | 20 | 11% |
| Series B | 11 | 6% |
| Pre-Seed | 10 | 6% |

12 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 70 | 39% |
| United States | 8 | 4% |
| Ghana | 1 | 1% |
| Canada | 1 | 1% |
| Australia | 1 | 1% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Amit Talia Alfasi | Marketing Communications and Investor Relations | 0 | https://shizune.co/investors/profile/amit-alfasi |
| Boaz Lifschitz | Managing General Partner & Co-Founder | 2 | https://shizune.co/investors/profile/boaz-lifschitz |
| Bryce Butler | Director | 2 | https://shizune.co/investors/profile/bryce-butler |
| David Eldar | Venture Partner, CFO | 0 | https://shizune.co/investors/profile/david-eldar |
| Elazer Edelman | Chairman of the medical advisory board | 0 | https://shizune.co/investors/profile/elazer-edelman |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Snipe Medical | Snipe Medical is a startup company, developing a novel solution to treat lung cancer. |  | Series A | Feb 05, 2026 |  |
| Ionara Bio | Ionara Bio is a biotech company that develops drugs for inflammatory responses. |  | Seed | Feb 01, 2026 |  |
| Stealth mode company | This company is currently operating in stealth mode.' |  | Seed | Feb 01, 2026 |  |
| Hairstetics | Hairstetics is a Health Care company. |  | Series A | Jan 03, 2026 |  |
| KAHR medical | KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $22M | Series B | Oct 15, 2025 |  |
| Terrapeutics Pharma | Terrapeutics Pharma develops a drug discovery platform that is based on a groundbreaking technology. | $725.8K | Seed | Oct 01, 2025 |  |
| BioRefine | Medical device company treating the mitral valve | $500K | Seed | Oct 01, 2025 |  |
| Raziel Therapeutics | Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity. | $212K | Venture - Series Unknown | Oct 01, 2025 |  |
| Aluma | Aluma is an endovascular company developing catheter integrated laser systems for precise treatment of small artery disease. | $780.8K | Seed | Oct 01, 2025 |  |
| Cordio Medical | CORDIO Medical provides groundbreaking solution | $1.3M | Venture - Series Unknown | Oct 01, 2025 |  |

10 of 180 investments shown.

## Co-investors
- [aMoon Fund](https://shizune.co/investors/profile/amoon) — VC Fund, 7 deals together
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund, 6 deals together
- [CPT Capital](https://shizune.co/investors/profile/cpt-capital) — VC Fund, 5 deals together
- [Jesselson Capital](https://shizune.co/investors/profile/jesselson-capital) — VC Fund, 4 deals together
- [Strauss Group](https://shizune.co/investors/profile/strauss-group) — VC Fund, 4 deals together
- [Accelmed](https://shizune.co/investors/profile/accelmed) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Peregrine Ventures invest in?

Peregrine Ventures invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 180 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Peregrine Ventures?

Public channels for Peregrine Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Peregrine Ventures?

The team at Peregrine Ventures includes Amit Talia Alfasi (Marketing Communications and Investor Relations), Boaz Lifschitz (Managing General Partner & Co-Founder) and Bryce Butler (Director), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co